Mangiferin: An effective therapeutic agent against several disorders

被引:115
作者
Du, Suya [1 ]
Liu, Huirong [2 ,3 ]
Lei, Tiantian [4 ]
Xie, Xiaofang [4 ]
Wang, Hailian [2 ,3 ]
He, Xia [3 ,5 ]
Tong, Rongsheng [3 ,5 ]
Wang, Yi [3 ,5 ]
机构
[1] Chengdu Mil Gen Hosp, Dept Pharm, Chengdu 610083, Sichuan, Peoples R China
[2] Sichuan Acad Med Sci, Inst Organ Transplantat, Chengdu 610072, Sichuan, Peoples R China
[3] Sichuan Prov Peoples Hosp, 32 West First Ring Rd, Chengdu 610072, Sichuan, Peoples R China
[4] Univ Elect Sci & Technol China, Sch Med, Chengdu 610054, Sichuan, Peoples R China
[5] Sichuan Acad Med Sci, Dept Pharm, Personalized Drug Therapy Lab Sichuan Prov, 32 West First Ring Rd, Chengdu 610072, Sichuan, Peoples R China
基金
美国国家科学基金会;
关键词
mangiferin; pharmacological activities; bioactive compound; structural modification; CELL-CYCLE ARREST; INDUCED MYOCARDIAL-INFARCTION; ISCHEMIA-REPERFUSION INJURY; CORONARY-HEART-DISEASE; L. EXTRACT VIMANG; NF-KAPPA-B; INDICA L; OXIDATIVE STRESS; MICROVASCULAR COMPLICATIONS; ANEMARRHENA-ASPHODELOIDES;
D O I
10.3892/mmr.2018.9529
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Mangiferin (1,3,6,7-tetrahydroxyxanthone-C2--D-glucoside) is a bioactive ingredient predominantly isolated from the mango tree, with potent antioxidant activity and multifactorial pharmacological effects, including antidiabetic, antitumor, lipometabolism regulating, cardioprotective, anti-hyperuricemic, neuroprotective, antioxidant, anti-inflammatory, antipyretic, analgesic, antibacterial, antiviral and immunomodulatory effects. Therefore, it possesses several health-endorsing properties and is a promising candidate for further research and development. However, low solubility, mucosal permeability and bioavailability restrict the development of mangiferin as a clinical therapeutic, and chemical and physical modification is required to expand its application. This review comprehensively analyzed and collectively summarized the primary pharmacological actions of mangiferin that have been demonstrated in the literature, to support the potential future development of mangiferin as a novel therapeutic drug.
引用
收藏
页码:4775 / 4786
页数:12
相关论文
共 116 条
  • [91] Non-adherence to self-care practices & medication and health related quality of life among patients with type 2 diabetes: a cross-sectional study
    Saleh, Farzana
    Mumu, Shirin J.
    Ara, Ferdous
    Hafez, Md Abdul
    Ali, Liaquat
    [J]. BMC PUBLIC HEALTH, 2014, 14
  • [92] Modulation of Diabetes and Dyslipidemia in Diabetic Insulin-Resistant Rats by Mangiferin: Role of Adiponectin and TNF-α
    Saleh, Samira
    El-Maraghy, Nabila
    Reda, Enji
    Barakat, Waleed
    [J]. ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS, 2014, 86 (04): : 1935 - 1947
  • [93] Insulin signalling and the regulation of glucose and lipid metabolism
    Saltiel, AR
    Kahn, CR
    [J]. NATURE, 2001, 414 (6865) : 799 - 806
  • [94] Pathophysiology of type 2 diabetes
    Scheen, AJ
    [J]. ACTA CLINICA BELGICA, 2003, 58 (06) : 335 - 341
  • [95] Sellamuthu PS, 2014, PAK J PHARM SCI, V27, P161
  • [96] Antihyperglycemic Effect of Mangiferin in Streptozotocin Induced Diabetic Rats
    Sellamuthu, Periyar Selvam
    Muniappan, Balu Periamallipatti
    Perumal, Sathiya Moorthi
    Kandasamy, Murugesan
    [J]. JOURNAL OF HEALTH SCIENCE, 2009, 55 (02) : 206 - 214
  • [97] Molecular mechanisms underlying mangiferin-induced apoptosis and cell cycle arrest in A549 human lung carcinoma cells
    Shi, Wei
    Deng, Jiagang
    Tong, Rongsheng
    Yang, Yong
    He, Xia
    Lv, Jianzhen
    Wang, Hailian
    Deng, Shaoping
    Qi, Ping
    Zhang, Dingding
    Wang, Yi
    [J]. MOLECULAR MEDICINE REPORTS, 2016, 13 (04) : 3423 - 3432
  • [98] Mangiferin inhibits endoplasmic reticulum stress-associated thioredoxin-interacting protein/NLRP3 inflammasome activation with regulation of AMPK in endothelial cells
    Song, Junna
    Li, Jia
    Hou, Fangjie
    Wang, Xiaona
    Liu, Baolin
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2015, 64 (03): : 428 - 437
  • [99] Protective effect of mangiferin on myocardial ischemia-reperfusion injury in streptozotocin-induced diabetic rats: role of AGE-RAGE/MAPK pathways
    Suchal, Kapil
    Malik, Salma
    Khan, Sana Irfan
    Malhotra, Rajiv Kumar
    Goyal, Sameer N.
    Bhatia, Jagriti
    Kumari, Santosh
    Ojha, Shreesh
    Arya, Dharamvir Singh
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [100] Natural dipeptidyl peptidase-IV inhibitor mangiferin mitigates diabetes- and metabolic syndrome-induced changes in experimental rats
    Suman, Rajesh Kumar
    Mohanty, Ipseeta Ray
    Maheshwari, Ujwala
    Borde, Manjusha K.
    Deshmukh, Y. A.
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2016, 9 : 261 - 272